Public Case Detail. Case Number : Reaction : Medicine details : Cases Count: 15. Gender : Weight (kg) : 36Y. Hospitalisation : Age :
|
|
|
- Gwen Carter
- 5 years ago
- Views:
Transcription
1 Case Number : /8/27 M 36Y Unknown Urticaria Reason : Tablet 4 Milligram 2 times Oral CITALOPRAM HYDROBROMIDE (Other drug) Reason : 4 Milligram Oral PUTRAN2 Page 1 of 18
2 Case Number : M 3/1/27 9/4/1937 Unknown Dscharge summary from psychatric hospital-final diagnoses-chronic delirium secondary to drug and medical causes. No indication of depression. Disorientation Aggression Agitation Confusional state Delirium Oedema Paranoia Psychotic disorder Disoriented, psychotic paranoia, agitated depression. Became delirious. Reported that he had attacked one of the nurses who was tyrying to restrain him. Oedema. Ceased Panadeine forte. Prescribed Zyprexa. Taken off Zyprexa and Edronax. Put on Risperidone. Had a minder in lock up situation for a week. Taken off Imovane and Risperidone. Given Endone. Taken off Mirtazapine. Tablet 12 Milligram Daily Oral IMOVANE (Suspected) Reason : Specific disorders of sleep Tablet 7.5 Milligram Daily Oral PUTRAN2 Page 2 of 18
3 PANADEINE FORTE (Suspected) Reason : Pain 1 Dose Unspec Daily ASPIRIN (Other drug) Reason : DILATREND (Other drug) Reason : NOVORAPID (Other drug) Reason : PANTOPRAZOLE (Other drug) Reason : PROTAPHANE (Other drug) Reason : PUTRAN2 Page 3 of 18
4 Case Number : /1/27 1/6/27 Not yet recovered F 74 52Y Hepatitis Incapacity/disability suspected drug induced hepatitis Hypertension Incapacity/disability Visual impairment Incapacity/disability Tablet 4 Milligram 2 times Oral Batch : Started : 1/3/25 Stopped : Lexapro (Suspected) Tablet 3 Milligram 1 time Oral Batch : Started : 3/6/26 Stopped : PUTRAN2 Page 4 of 18
5 Case Number : F 13/11/ /1/26 26/6/197 Not yet recovered is a seq of Nausea I am currently treated each symptom experiencing severe constipation despite eating fibre rich food etc. I also experience headaches over my left eye and still suffer from numbness around my left eye socket. I occasionally get the same tightness in my chest. I am now so loath to return to a doctor about these issues because of my experience late last year and early this year. Just last night I researched on the internet whether or not the Edronax could account for my range of symptoms and discovered that indeed it could! This is why I am now reporting all of them to this website. It's been over a year since I increased the dosage from 8mg to 12mg and it's been within that timeframe that I've experienced all of these symptoms. Chest pain Constipation Dizziness Headache Hypoaesthesia Hypotension Liver tenderness Lymphadenopathy Palpitations Syncope Vomiting Weight decreased PUTRAN2 Page 5 of 18
6 Tablet 4 Milligram 3 times Oral Batch : D832A Started : 6/1/26 Stopped : Laboratory Investigations : Type Range Date Tested Result Details Other data Ordered blood tests and CT scans of chest, abdomen and pelvis, these all came back negative for a cancer recurrence. Was tested for TB and some types of infectous diseases. These were also negative. Magnetic Resonance Imaging MRI of brain to check that there was no recurrence of breast cancer and still every test all came negative. PUTRAN2 Page 6 of 18
7 Case Number : /1/28 M 67Y Recovered Causality probable Dysuria Urinary retention 1.5 Dose Unspec Daily Oral PUTRAN2 Page 7 of 18
8 Case Number : M 29/2/28 68 Required a visit to the doctor 19/11/27 2/1/198 11/2/28 Recovered Penile discharge Penile discharge started after increasing from 8mg to 1mg Reboxetine. Reduce dose REBOXETINE MESYLATE (Suspected) 1 Milligram Daily Batch : Started : 18/11/27 Stopped : 11/2/28 PUTRAN2 Page 8 of 18
9 Case Number : M 2/4/28 99u Unknown Weight decreased weight loss, fall, increased Sudafed. blood pressure, erectile dysfunction, sinus congestion, appetite loss, pulse increased, mood swings, hot flushes, sweating, nausea, vomiting, fatigue, dizziness, chills, itching. Anorexia Blood pressure increased Chills Dizziness Erectile dysfunction Fatigue Heart rate increased Hot flush Hyperhidrosis Mood swings Nausea Pruritus Sinus congestion Syncope Vomiting PUTRAN2 Page 9 of 18
10 Case Number : M 29/4/28 99u Not yet recovered Dose of Efexor XR was not decreased gradually before commencing Edronax. Suicidal ideation Switched from Efexor XR to Edronax. Experienced suicidal thoughts, Edronax ceased and Xanax commenced until he is able to see his doctor again. aggression toward his wife and dizzy spells. Aggression Dizziness Reason : 8 Milligram Daily Batch : Started : 15/4/28 Stopped : EFEXOR-XR (Suspected) Reason : 15 Milligram Daily 15/4/28 PUTRAN2 Page 1 of 18
11 Case Number : M 6/6/28 31/5/28 15/1/1939 Recovered Dry mouth Anxiety Balance disorder Confusional state Dizziness Hyponatraemia Dry mouth, confusion, increased anxiety, dizziness, increasing problems with balance, hyponatraemia (111mmol/L) Reason : Tablet 8 Milligram 2 times Oral Batch : F65B Started : 15/5/28 Stopped : 31/5/28 CALTRATE (Other drug) Reason : Tablet 6 Milligram Daily Oral COLOXYL WITH SENNA (Other drug) Reason : As necessary NEXIUM (Other drug) Reason : Tablet 2 Milligram Daily Oral PANAMAX (Other drug) Reason : Cessation of Edronax and sodium replacement with IV isotonic saline PUTRAN2 Page 11 of 18
12 Laboratory Investigations : Type Range Date Tested Result Details Sodium 31/5/ sodium 128mmol/L on at 55 follwoing replacement with isotonic saline. Sodium 1/6/ sodium 128mmol/L on at 55 follwoing replacement with isotonic saline. PUTRAN2 Page 12 of 18
13 Case Number : F 2/6/28 Treated in outpatient department only. 23/4/28 16/3/1976 Not yet recovered Urinary retention Urinary retention Prazosin, IDC REBOXETINE MESYLATE (Suspected) 8 Milligram Daily Oral 23/4/28 ALPRAZOLAM (Other drug) Reason : 2 Milligram Daily OXYNORM (Other drug) Reason : 3 Milligram Daily PARACETAMOL (Other drug) Reason : 5 Milligram As necessary SALAZOPYRIN (Other drug) Reason : 2 Gram Daily SEROQUEL (Other drug) Reason : 2 Milligram Daily Zolpidem tartrate (Other drug) Reason : 12.5 Milligram Daily PUTRAN2 Page 13 of 18
14 Case Number : /6/28 Required a visit to the doctor 21/5/28 16/6/28 Recovered F 45 2/2/1958 Was on Edronax 4mg/daily and was fine, problems when dose increased. Angioedema Angioedema Tablet 6 Milligram Daily Oral Batch : Started : 21/5/28 Stopped : 3/5/28 LIPITOR (Other drug) Reason : Tablet 2 Milligram Daily Oral Batch : Started : L TERM Stopped : LOSEC (Other drug) Reason : 2 Milligram Daily Batch : Started : L TERM Stopped : PUTRAN2 Page 14 of 18
15 Case Number : M 28/7/28 99u 22/9/27 Recovered Stevens-Johnson syndrome Stevens-Johnson like Drug withdrawn reaction Erythema multiforme Urticaria papular Tablet 16 Milligram Daily Oral Batch : Started : 6/9/27 Stopped : 23/9/27 Escitalopram (Other drug) Reason : 1 Milligram Oral Batch : Started : 9/8/27 Stopped : PUTRAN2 Page 15 of 18
16 Case Number : F 24/9/28 1/9/1951 Causality probable Recovered Female sexual arousal Persistent genital arousal Edronax was discontinued. disorder syndrome 4 Milligram Daily Oral Batch : Started : 15/9/27 Stopped : 1/8/28 EPILIM (Other drug) Reason : Lexapro (Other drug) Reason : PUTRAN2 Page 16 of 18
17 Case Number : M 25/9/28 31/12/1949 Causality probable Recovered Urinary retention Urinary Retention after increasing dose from 2mg daily to 4 mg daily. Edronax ceased. Tablet 4 Milligram Daily Oral Batch : Started : 31/7/28 Stopped : 6/8/28 AVAPRO (Other drug) Reason : Lexapro (Other drug) Reason : MEGAFOL (Other drug) Reason : PARIET (Other drug) Reason : PUTRAN2 Page 17 of 18
18 Case Number : F 28/1/29 Required a visit to the doctor 3/12/28 4/8/1922 Not yet recovered Lethargy Lethargy, muscle Ceased medication weakness, abdominal pain. Abdominal pain Myalgia Tablet 8 Milligram Daily Oral Batch : Started : 28/11/28 Stopped : 8/12/28 COVERSYL (Other drug) Reason : INSULIN NOS (Other drug) Reason : METFORMIN HYDROCHLORIDE (Other drug) Reason : Selection Parameters : Date Range: 1/8/27 To 31/1/29 Unclear causality excluded GM medicines Only Medicine Names: EDRONAX, REBOXETINE MESYLATE PUTRAN2 Page 18 of 18
Public Case Detail. Preferred Term Severity Report Description Treatment Suicidal ideation Suicidal thoughts. Ceased Cymbalta
Case Number : 242267 25/6/28 28/5/28 Unknown M 25Y Suicidal ideation Suicidal thoughts. Ceased Cymbalta Cymbalta (Suspected) Capsule 6 Milligram Daily Oral Batch : Started : 23/5/28 Stopped : 29/5/28 PUTRAN2
Database of Adverse Event Notifications - medicines
Database of Adverse Event Notifications - medicines You searched for the following 3 medicines between 01/01/2017 01/01/2018: Ferinject 100mg/2mL (Ferric carboxymaltose) Ferinject 500mg/10mL (Ferric carboxymaltose)
Medication is just part of the management of these illnesses. Other therapies are also helpful; you may wish to discuss these with your prescriber.
Know Your Medicines Duloxetine The purpose of this leaflet is to give you some general information on duloxetine, and is intended as a guide only. This should be read in conjunction with the official patient
PFIZER INC. THERAPEUTIC AREA AND FDA APPROVED INDICATIONS: See United States Package Insert (USPI)
PFIZER INC. These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert. For publications based on this study, see associated bibliography.
KEY MESSAGES. It is often under-recognised and 30-50% of MDD cases in primary care and medical settings are not detected.
KEY MESSAGES Major depressive disorder (MDD) is a significant mental health problem that disrupts a person s mood and affects his psychosocial and occupational functioning. It is often under-recognised
ANTI-DEPRESSANT MEDICATIONS
ANTI-DEPRESSANT MEDICATIONS This information is not intended to be a substitute for medical advice. It s purpose is solely informative. If your client or yourself are taking antidepressants, do not change
Guidelines MANAGEMENT OF MAJOR DEPRESSIVE DISORDER (MDD)
MANAGEMENT OF MAJOR DEPRESSIVE DISORDER (MDD) Guidelines CH Lim, B Baizury, on behalf of Development Group Clinical Practice Guidelines Management of Major Depressive Disorder A. Introduction Major depressive
Bridges Family Wellness PC. New Patient Intake. Bridges Family Wellness Intake Form SE Lake Rd, Suite 102 Milwaukie, OR
New Patient Intake Bridges Family Wellness Intake Form Full Name: * What is your birthdate? MM/DD/YYYY * What is your gender identity? * Home address: * Cell Phone * Other Phone number(s): Emergency Contact
CECILIA P MARGRET MD PhD MPH Child, Adolescent and Adult Psychiatry NE 24th ST Suite 104, Bellevue WA 98007, Phone / Fax: +1 (425)
IDENTIFYING INFORMATION PATIENT INFORMATION FORM Patient's Name: DOB: Ethnicity/race: Gender: Primary language if other than English: Address: Phone: Home/ Mobile/ Work Email: Occupation: Marital Status:
Continence PGD transdermal oxybutynin Kentera patch 36mg
Continence PGD transdermal oxybutynin Kentera patch 36mg Patient group direction for the supply of transdermal oxybutynin Kentera patch 36mg to patients suffering from urinary frequency, urgency or incontinence
Summary details of suspected adverse reactions/events associated with the use of Gardasil 1st March st March 2015
Page 1 of 6 Adverse (s) Date Outcome 2014-019844 04/03/2014 13 Years Prophylaxis GARDASIL 04/12/2013 Nausea 04/12/2013 06/12/2013 Headache 04/12/2013 06/12/2013 Vomiting 04/12/2013 06/12/2013 Asthenia
Overview of reports of adverse drug reactions associated with changes of the package of Thyrax (levothyroxine) from a bottle to a blister
Overview of reports of adverse reactions associated with changes of the package of from a bottle to a blister Introduction The was granted marketing authorization in the Netherlands on 6 June, 1980. Levothyroxine
CORE SAFETY PROFILE OXYCODONE HYDROCHLORIDE NL/H/PSUR/0054/ January 2013
CORE SAFETY PROFILE OXYCODONE HYDROCHLORIDE NL/H/PSUR/0054/001 16 January 2013 1 4.2 Posology and method of administration (safety aspects only) Posology Elderly patients For oral preparations A dose adjustment
Liposomal Doxorubicin (CAELYX) Gynaecological Cancer
Systemic Anti Cancer Treatment Protocol Liposomal Doxorubicin (CAELYX) Gynaecological Cancer PROCTOCOL REF: OPHAGYNCAE (Version No: 1.0) Approved for use in: Advanced ovarian cancer second/third line treatment
28-DAY CLEANSE GUT C.A.R.E. by Dr. Vincent Pedre. Pre-Program Medical Symptoms Questionnaire
28-DAY CLEANSE HAPPY GUT GUT C.A.R.E. by Dr. Vincent Pedre Pre-Program Medical Symptoms Questionnaire NAME ADDRESS EMAIL PHONE RATE EACH OF THE FOLLOWING SYMPTOMS BASED UPON HOW YOU HAVE FELT OVER THE
MabThera. SC. The wait is over. MabThera delivered in just 5 minutes. SC= subcutaneous injection
MabThera SC. The wait is over. MabThera delivered in just 5 minutes Abbreviated Prescribing Information MabThera 1400 mg solution for subcutaneous (SC) injection (Rituximab) Indications: Indicated in adults
MEDICINE SUMMARY. Atomoxetine Hydrochloride Layer 1 of 8 ALL REPORT DATES. Tachycardia. Supraventricular tachycardia. Palpitations.
Atomoxetine Hydrochloride Layer 1 of 8 ALL REPORT DATES Causality Unclear Exclud Total Sole Suspected - Cases Including Medicine - Occurrences of Medicine - Reactions Related to Medicine Blood and lymphatic
PERSONAL MEDICAL AND FAMILY HISTORY Please check applicable boxes.
Name: DOB: PERSONAL MEDICAL AND FAMILY HISTORY Please check applicable boxes. TOBACCO USE: Quit Date Cigarettes Packs/Day Number of years smoked Pipe/Cigar Smokeless Tobacco Electronic or E-cigarette Secondhand
Public Case Detail. Causality probable Recovered. Changed to Ritalin LA 40 mg and Ritalin 20 mg and has been fine since
Case Number : 195519 16/03/2004 66 18/12/1987 Causality probable Recovered Changed to Ritalin LA 40 mg and Ritalin 20 mg and has been fine since Headache Headaches, sweating, mood swings, not eating. Ceased
SMOKING CESSATION IS HARD
POWER TO BREAK THE HOLD OF NICOTINE ADDICTION 1 SMOKING CESSATION IS HARD Most smokers try to quit 5-7 times before they are successful. 2 Why is it so hard to quit? Typical withdrawal symptoms from stopping
Dementia Medications Acetylcholinesterase Inhibitors (AChEIs) and Glutamate (NMDA) Receptor Antagonist
Dementia Medications Acetylcholinesterase Inhibitors (AChEIs) and Glutamate (NMDA) Receptor Antagonist Medication Dosage Indication for Use Aricept (donepezil) Exelon (rivastigmine) 5mg 23mg* ODT 5mg Solution
THE MANY SYMPTOMS ROOTED IN HORMONE IMBALANCES
abdominal pain acne aging process accelerated allergies, including asthma, hives, rashes, sinus congestion anemia (blood hemoglobin low) anorexia anovulatory (no ovulation) anxiety anxious depression appetite
Appendix 4B - Guidance for the use of Pharmacological Agents for the Treatment of Depression in Adults (18 years and over)
Appendix 4B - Guidance for the use of Pharmacological Agents for the Treatment of Depression in Adults (18 years and over) Introduction / Background Treatment comes after diagnosis Diagnosis is based on
Integrative Consult Patient Background Form
Let Us Know More - So We Can Help Thank you for choosing to schedule an integrative medicine consultation with UC Health. To help us meet your needs during your visit, please take some time to sit in a
Migraleve, Migraleve Pink and Migraleve Yellow Product Information
Migraleve, Migraleve Pink and Migraleve Yellow Product Information Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard Adverse events should also
JOHN MICHAEL ROACH, MD
GASTROENTEROLOGY JOHN MICHAEL ROACH, MD 520 N. 4 TH AVE. PASCO, WA 99301 Phone: (509) 546-8383 Name: Date of Birth: First Middle (full) Last m/d/yr Primary care provider: Referring physician: Local Pharmacy:
RABEPRAZOL 10mg and 20mg Gastro-resistant Tablets
PACKAGE LEAFLET: INFORMATION FOR THE USER RABEPRAZOL 10mg and 20mg Gastro-resistant Tablets RABEPRAZOLE This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet
Patient Name Date of Birth Page 1 of 6
2545 W. Hillcrest Dr. #205 Thousand Oaks, CA 91320 Admissions: 888.822.8938 Fax: 805.273.5246 Dear Medical Professional, This patient is seeking care to address eating disorder behaviors. For the patient
New Patient Medical History Intake Form
New Patient Medical History Intake Form Name: Todays Date: / / Date of Birth: / / Age: Gender: M / F Marital Status: S M D W Address: City: State: Zip Code Primary Ph.# (cell, hm, wk) Email Address 2nd
GET OFF YOUR ACID 7-DAY SUMMER CLEANSE Client Workbook
GET OFF YOUR ACID 7-DAY SUMMER CLEANSE Client Workbook Before getting started, let s do a physical and emotional inventory of where you are now. Starting point: Weight Energy (1-10, 10 being unstoppable)
CENTRAL CARE POLICY SYMPTOMS OF ILLNESS. Policy: Consumers will be observed for symptoms of physical problems, distress, pain, or unusual behaviors.
Page 1 of 5 CENTRAL CARE POLICY SYMPTOMS OF ILLNESS SUBJECT: SYMPTOMS OF ILLNESS ANNUAL REVIEW MONTH: June RESPONSIBLE FOR REVIEW: Director of Central Care LAST REVISION DATE: June 2009 Policy: Consumers
Schedule FDA & literature based indications
Psychotropic Medication List Recommended dosages are intended to serve only as a guide for children. Recommended doses are literature based. Clinicians should consult package insert of medications for
Symptom Review (page 1) Name Date
v2.4, 2/13 JonathanTreasure.com Botanical Medicine & Cancer Herb Drug Interactions Herbalism 3.0 Symptom Review (page 1) Name Date INSTRUCTIONS Please read each section below carefully and, after each
Office Use. Stage of. Technique/Plan +/- Change. Establishing Your Health Goals. Date: Name: Age: Referred by:
Establishing Your Health Goals Date: Name: Age: Referred by: Fill in your current Health Goals. Office Use Health Goals 1. Change +/- Stage of Change Technique/Plan 2. 3. 4. 5. 6. 7. 8. 9. 10. FLT Personal
PATIENT SLEEP QUESTIONNAIRE
PATIENT SLEEP QUESTIONNAIRE Name: Date of Birth: Today s Date Primary Care Physician Telephone # Physician ordering test (Other than PCP): Physician s Tel. #: _ Age: Years Height: Feet Inches Weight: Lb
Raritan Bay Medical Center
Raritan Bay Medical Center For any question regarding Med of the Month. You may contact : Sherr Ann Arabit MSN, RN-BC, CCRN Professional Development Department Ext 4196 1 Professional Development Presents
Patient Information. Marital Status (Single, Married, Life Partner, Divorced, Widowed) CHIEF COMPLAINT
Patient Information Name Date Home Address City State Zip Phone E-mail Address Cell Phone: Business Address City State Zip Phone Occupation Place of Birth Date of Birth Age Height Weight Soc. Sec. # Sex
Headache Follow-up Visit Form
!1 Headache Follow-up Visit Form We will be unable to see you unless this form is completely filled out. We appreciate your thoroughness. Name DOB Age Today s Date Referring doctor: Primary doctor: Neurologist:
+ Color Change - + Hearing Loss - + Apnea - + Enuresis (urine - + Tremors - + Rash -
Review of Systems: 0-1 year old Constitution neg Eyes neg GI neg Neurological neg + Activity Change - + Eye Discharge - + Reflux - + Facial Asymmetry - + Appetite Change - + Eye Redness - + Vomiting -
PACKAGE LEAFLET: INFORMATION FOR THE USER
PACKAGE LEAFLET: INFORMATION FOR THE USER 250 mg film-coated tablets. 500 mg film-coated tablets. 750 mg film-coated tablets. 1000 mg film-coated tablets. Levetiracetam
NORVASC 5 mg and 10 mg tablets
PACKAGE LEAFLET: INFORMATION FOR THE USER NORVASC 5 mg and 10 mg tablets AMLODIPINE This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine, which
Public Case Detail. Case Number : Reaction : Medicine details : Cases Count: 87. Gender : /08/2007. Weight (kg) : Data Entry Date :
Case Number : 23147 2/8/27 6.2 2/6/27 1/2/1927 Not yet recovered Adverse reaction to haloperidol and metoclopramide. On 25mg bd at time of admission 2/5/7, dosage incrementally increased in effect to manage
4/2/13 COMMON CLASSES OF MEDICATIONS. Child & Adolescent Behavioral Medicine & Medication Therapies. Behavioral Medicine & Medication Therapies
Child & Adolescent Behavioral Medicine & Medication Therapies Brian J Cowles, PharmD Associate Professor of Pharmacy Practice Albany College of Pharmacy & Health Sciences; Vermont Campus Behavioral Medicine
Public Case Detail. Causality possible Recovered
Case Number : 233493 M 18/9/27 Admitted to hospital 27/8/27 8/6/1968 2/9/27 Patient received haloperidol 2.5mg-5mg prn 3 doses. haloperidol 2/8/27 2 doses, 24/8/27 one dose, 25/8/27 one dose, 31/8/27 2.5mg,
READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION ORILISSA. elagolix (as elagolix sodium) tablets
READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION ORILISSA elagolix (as elagolix sodium) tablets Read this carefully before you start taking ORILISSA and each time you
lexapro 8 Lexapro and cold symptoms Lexapro without weight gain, methadone zoloft and lexapro. 9 Is lexapro like zoloft
How long does take to wear off, help you to sleep overtime, dosage for ocd treatment, withdrawal cold sweats, social anxiety dosage. Lexapro dose for ocd, can't think straight, pros and cons of the depression
Case Series Drug Analysis Print Name: Vaxigrip, Fluarix, Inflexal V og Influenzacvaccine 01Sep Oct2014
- 16Oct2014 Report Run Date: 20-Oct-2014 Data Lock Date: 16-Oct-2014 19:00:06 Earliest Reaction Date: 28-Oct-2009 MedDRA Version: MedDRA 17.0 Vaxigrip, Fluarix, Inflexal V og Influenzacvaccine : Alle cases
GREATER MANCHESTER INTERFACE PRESCRIBING GROUP
GREATER MANCHESTER INTERFACE PRESCRIBING GROUP On behalf of the GREATER MANCHESTER MEDICINES MANAGEMENT GROUP SHARED CARE GUIDELINE FOR THE PRESCRIBING OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)
Reduce hunger and help control cravings with CONTRAVE
Reduce hunger and help control cravings with CONTRAVE Understanding and identifying patients who are ready to start their weight-loss journey with CONTRAVE is key to helping them reach their weight-loss
Minor Intake Form. Child s Name DOB
Page 1 of 5 Minor Intake Form Child s NameDOB Current Concerns: What concern brings you or your child in? When did this concern begin? (Please attempt to use dates.) Has your family/child been in therapy
MEDICATION GUIDE Savella (Sa-vel-la) (milnacipran HCl) Tablets
FDA-Approved Medication Guide MEDICATION GUIDE Savella (Sa-vel-la) (milnacipran HCl) Tablets Savella is not used to treat depression, but it acts like medicines that are used to treat depression (antidepressants)
Summary listing of suspected adverse reactions and events associated with use of Gardasil 01/06/ /12/2015
1 2015-023780 2015-023788 2015-023805 2015-023819 2015-023820 2015-023821 Injection site swelling Transient immobility Abdominal pain Visual acuity reduced Chronic fatigue syndrome Mental disorder Pallor
Please list any treatments you have previously had for current illness. (Physical Therapy, Surgery, Radiation, etc.)
Date: Patient Name: D.O.B Last First M.I History of Present Illness: What is the reason for your visit? Date symptom started? Please list any treatments you have previously had for current illness. (Physical
Medication Management. Dr Ajith Weeraman MBBS, MD (Psychiatry), FRANZCP Consultant Psychiatrist Epworth Clinic Camberwell 14 th March 2015
Medication Management Dr Ajith Weeraman MBBS, MD (Psychiatry), FRANZCP Consultant Psychiatrist Epworth Clinic Camberwell 14 th March 2015 1 Medication Management Objectives: 1. Principles of psycho-pharmacology
DOES WELLBUTRIN HELP DEPRESSION
DOES WELLBUTRIN HELP DEPRESSION Does Wellbutrin Help Depression Wellbutrin benefits for women Wellbutrin xl rash face Be put on wellbutrin Wellbutrin false positive thc Wellbutrin avoidant personality
Study No.: Title: Phase: Study Period: Study Design: Centres: Indication: Treatment: Objectives: Primary Outcome/Efficacy Variable:
The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.
Broward Oncology Associates, P.A. PATIENT INFORMATION
NAME: BIRTHDATE: AGE: LOCAL ADDRESS (Street city state zip): HOME TELEPHONE# CELL # SOCIAL SECURITY #: - - SEX MARITAL STATUS WHAT IS YOUR HT? WHAT IS YOUR WT? EMPLOYER WORK# SPOUSE'S NAME SPOUSE'S EMPLOYER
Who is filling out this intake form? Self Spouse Parent Guardian
Office Use Only: Reviewed with Patient Data Entry Scan & File Date: Date: Date: Initials: Initials: Initials: Today s Date: Who is filling out this intake form? Self Spouse Parent Guardian If you are not
PRODUCT MONOGRAPH. (Atomoxetine Capsules) 10 mg, 18 mg, 25 mg, 40 mg, 60 mg, 80 mg and 100 mg atomoxetine (as atomoxetine hydrochloride)
PRODUCT MONOGRAPH Pr RIVA-ATOMOETINE (Atomoxetine Capsules) 10 mg, 18 mg, 25 mg, 40 mg, 60 mg, 80 mg and 100 mg atomoxetine (as atomoxetine hydrochloride) Professed Standard Selective Norepinephrine Reuptake
LEXAPRO PRESENT TENSE SPANISH VERB CONJUGATIONS SPANISH VERBS
LEXAPRO PRESENT TENSE SPANISH VERB CONJUGATIONS SPANISH VERBS Lexapro Present Tense Spanish Verb Conjugations Spanish Verbs Withdrawal rash lexapro skin Lexapro trazodone and weight And electricity on
Carboplatin / Liposomal Doxorubicin CARBO/CAELYX Gynaecological Cancer
Systemic Anti Cancer Treatment Protocol Carboplatin / CARBO/CAELYX Gynaecological Cancer PROCTOCOL REF: MPHAGYNCCX (Version No: 1.0) Approved for use in: Advanced ovarian cancer in women who have progressed
PACKAGE LEAFLET: INFORMATION FOR THE USER. Cinfalair 4 mg chewable tablets
PACKAGE LEAFLET: INFORMATION FOR THE USER Cinfalair 4 mg chewable tablets Read all of this leaflet carefully before your child starts taking this medicine. Keep this leaflet. You may need to read it again.
Bodily Conditions Rooted in Hormone Imbalance
Check this list for all conditions that apply to you. The total possible score is 209. Count the number of symptoms you check. The higher your score, the more likely you need to address hormone imbalances.
Medication Guide Fluoxetine Tablets, USP
Medication Guide Fluoxetine Tablets, USP Read the Medication Guide that comes with fluoxetine before you start taking it and each time you get a refill. There may be new information. This Medication Guide
PATIENT INFORMATION LEAFLET AMLOC RANGE
SCHEDULING STATUS: S3 PROPRIETARY NAME AND DOSAGE FORM: AMLOC 5 mg tablets AMLOC 10 mg tablet Read all of this leaflet carefully before you start taking AMLOC. Keep this leaflet. You may need to read it
Objectives. 3HP and Flu Syndrome What is the Underlying Mechanism? Case #1 3/23/2016. Christina T. Fiske, MD MPH March 30, 2016
Objectives 3HP and Flu Syndrome What is the Underlying Mechanism? Christina T. Fiske, MD MPH March 30, 2016 Illustrate the side effect of 3HP flu like syndrome after its initiation to raise awareness in
Emotional Relationships Social Life Sexually Recreation
Name Date Address City State Zip Married Single Partner Divorced Widowed Date of Birth SS# Email Work Phone Home Phone Cell Phone Occupation Referred by Emergency Contact Family Physician Contact May we
Norpramin (desipramine)
Generic name: Desipramine Available strengths: 10 mg, 25 mg, 50 mg, 75 mg, 100 mg, 150 mg tablets Available in generic: Yes Drug class: Tricyclic antidepressant General Information Norpramin (desipramine)
Inner Balance Acupuncture
Patient Information Inner Balance Acupuncture 274 Southland Drive, Suite 101, Lexington, KY 40503 859-595-2164 www.acupunctureky.com Name: Today s date: Age: Male Female Marital status: Date of Birth:
New Patient Pain Evaluation
New Patient Pain Evaluation Name: Date: Using the following symbols, mark the areas of the body diagrams which are affected by your pain: \\ = Stabbing * = Electrical X = Aching N = Numbness 0 = Dull S
New Patient Specialty Intake Form Department of Surgery
This form contains questions specific to the Department of Surgery. If you are new to Baylor College of Medicine and have not been seen in any of our offices, please be sure to complete our New Patient
PAIN RELIEF AFTER SURGERY
PAIN RELIEF AFTER SURGERY Postoperative pain can last for days, weeks or even months. The amount of pain you experience depends on the type of operation and varies widely between patients, even for the
M0BCore Safety Profile. Active substance: Bromazepam Pharmaceutical form(s)/strength: Tablets 6 mg FR/H/PSUR/0066/001 Date of FAR:
M0BCore Safety Profile Active substance: Bromazepam Pharmaceutical form(s)/strength: Tablets 6 mg P-RMS: FR/H/PSUR/0066/001 Date of FAR: 26.11.2013 4.3 Contraindications Bromazepam must not be administered
Venlafaxine hydrochloride extended-release and other antidepressant medicines may cause serious side effects, including:
Medication Guide VENLAFAXINE XR (venlafaxine hydrochloride) (Extended-Release Capsules) Read the Medication Guide that comes with venlafaxine hydrochloride extended-release before you start taking it and
This initial discovery led to the creation of two classes of first generation antidepressants:
Antidepressants - TCAs, MAOIs, SSRIs & SNRIs First generation antidepressants TCAs and MAOIs The discovery of antidepressants could be described as a lucky accident. During the 1950s, while carrying out
Drug Resistant Tuberculosis Self-reporting of Drugrelated. During Treatment
Drug Resistant Tuberculosis Self-reporting of Drugrelated Adverse Events During Treatment Introduction This information has been prepared for people with tuberculosis (TB) that is resistant to the commonly
Have you already tried different drugs for your schizophrenia? Here s another option you and your doctor may want to consider.
Have you already tried different drugs for your schizophrenia? Here s another option you and your doctor may want to consider. 1 Benefits of Clozapine Clozapine may work when other medications don t. Doctors
PRODUCT INFORMATION. SUDAFED Sinus 12 Hour Relief Tablets
PRODUCT INFORMATION SUDAFED Sinus 12 Hour Relief Tablets NAME OF THE MEDICINE Pseudoephedrine Hydrochloride CAS 2 Registry Number: 345-78-8 DESCRIPTION SUDAFED Sinus 12 Hour Relief prolonged-release tablets
Shared Care Guideline
Shared Care Guideline Rotigotine Executive Summary Indication: Parkinson s disease, either alone or as an adjunct to co-beneldopa or co-careldopa. Patient Group: Patients with early-stage idiopathic Parkinson
Patient Information Montelukast Sodium Tablets and Montelukast Sodium Chewable Tablets
Patient Information Montelukast Sodium Tablets and Montelukast Sodium Chewable Tablets Read the Patient Information Leaflet that comes with montelukast sodium before you start taking it and each time you
Treat mood, cognition, and behavioral disturbances associated with psychological disorders. Most are not used recreationally or abused
Psychiatric Drugs Psychiatric Drugs Treat mood, cognition, and behavioral disturbances associated with psychological disorders Psychotropic in nature Most are not used recreationally or abused Benzodiazepines
Dexamethasone is used to treat cancer. This drug can be given in the vein (IV), by mouth, or as an eye drop.
Dexamethasone Other Names: Decadron About This Drug Dexamethasone is used to treat cancer. This drug can be given in the vein (IV), by mouth, or as an eye drop. Possible Side Effects (More Common) Increased
Corinna Mosher, M.D. A Medical Corporation 415 E. Rolling Oaks Drive Suite #280 Thousand Oaks, CA (805) Fax (805)
Patient Registration: Corinna Mosher, M.D. A Medical Corporation 415 E. Rolling Oaks Drive Suite #280 Thousand Oaks, CA 91361 (805) 496-8522 Fax (805) 496-0469 Last Name: First Name: MI: Address: City:
Health History. Tests and Procedures: Test: Date: Location: Provider: Abnormal: Results/Notes: Monthly self breast exam. Last mammogram (female)
Comprehensive Cancer Center A Cancer Center Designated by the National Cancer Institute Please answer the following questions and bring this form to your first appointment at Rutgers Cancer Institute of
Complete the CE Checklist for Customized Symptoms. Page 1 of 6
Progress Tracking Complete the CE Checklist for Customized Symptoms Page 1 of 6 Generic Positive Symptom Tracking Concentration Quality Of Sleep Motivation/Energy Patience Short Term Memory Appetite Positive
Continence PGD - Oxybutynin 5mg Modified Release
Continence PGD - Oxybutynin 5mg Modified Release Patient group direction for the supply of Oxybutynin Lyrinel XL 5mg and 10mg tablets, maximum dose of 20mg/day to patients suffering from urinary frequency,
TAKING LUVOX AND WELLBUTRIN TOGETHER
TAKING LUVOX AND WELLBUTRIN TOGETHER Taking Luvox And Wellbutrin Together Wellbutrin make you sleepy Wellbutrin and low white blood cells Wellbutrin used with lexapro Wellbutrin xl full effect Wellbutrin
Home Address: City: State: Zip Code: Referral Source (Therapist, Treatment Program, Etc...): Name: Age: Gender: Name: Age: Gender: Name: Age: Gender:
Naltrexone Pellet Insertion Intake Form Name: Date of Birth: / / Contact Information: Phone: E-Mail: Home Address: City: State: Zip Code: Referral Source (Therapist, Treatment Program, Etc...): Why are
I. ALL CLAIMS: HEALTH CARE PROFESSIONALS
HCP Prescribing Information Date/Version January 2015 Version 2 Page: 1 of 5 I. ALL CLAIMS: HEALTH CARE PROFESSIONALS Indications and Usage Saxenda (liraglutide [rdna origin] injection) is indicated as
KAMIREN PACKAGE LEAFLET: INFORMATION FOR THE USER. What is in this leaflet? 1. WHAT KAMIREN IS AND WHAT IT IS USED FOR
PACKAGE LEAFLET: INFORMATION FOR THE USER KAMIREN 2 mg, 4 mg TABLETS DOXAZOSIN This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine, which outlines
Public Case Detail. Case Number : Reaction : Medicine details : Cases Count: 76. Gender : 02/08/2007. Data Entry Date : Weight (kg) : Age :
Case Number : 231443 2/8/27 62 1/1/1971 Recovered with sequelae Subdural haematoma had a fit and had a severe head injury described as severe intracranial bleed and hematoma Convulsion Zeldox (Suspected)
0BCore Safety Profile. Pharmaceutical form(s)/strength: Losec MUPS tablets 10, 20 mg (OTC) NL/H/PSUR/0058/001 Date of FAR:
0BCore Safety Profile Active substance: Omeprazole Pharmaceutical form(s)/strength: Losec MUPS tablets 10, 20 mg (OTC) P-RMS: NL/H/PSUR/0058/001 Date of FAR: 13.06.2013 4.2 Posology and method of administration
1.1. An overview of reports on sitagliptin
1.1. An overview of reports on Introduction Sitagliptin (Januvia ) was registered for the European marked on March 21 st 27 with the Netherlands as rapporteur. It is indicated as treatment of for patients
PSYCHIATRIC DRUGS. Mr. D.Raju, M.pharm, Lecturer
PSYCHIATRIC DRUGS Mr. D.Raju, M.pharm, Lecturer PSYCHIATRIC DRUGS Treat mood, cognition, and behavioral disturbances associated with psychological disorders Psychotropic in nature Most are not used recreationally
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT YOCON-GLENWOOD Tablets 5 mg 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 1 tablet contains 5 mg yohimbine hydrochloride. For a full list of excipients, see section 6.1. 3
Amarillo Surgical Group Doctor: Date:
Office Visit Information (General Surgery) Amarillo Surgical Group Doctor: Date: Patient s Information Name: Last First Middle Social Security #: Date of Birth: Age Gender: [ Male / Female ] Marital Status:
Information leaflet for primary care: Agomelatine
Information leaflet for primary care: Agomelatine Background information Agomelatine is an antidepressant indicated for the treatment of major depressive episodes in adults. Agomelatine is a melatonin
Referring Physician/Therapist. Primary Care Physician. Reason for Visit
Name Age Date Referring Physician/Therapist Primary Care Physician Reason for Visit If you are having pain, use the diagram and symbols to indicate where it is. Ache: AAA Burning:XXX Numbness:OOO Pins/Needles: